G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells : caveolin-1 as a marker of cytotoxicity.

DC FieldValueLanguage
dc.contributor.authorRoussel, Élise-
dc.contributor.authorBélanger, Martin-
dc.contributor.authorCouët, Jacques-
dc.date.accessioned2017-11-14T18:45:28Z-
dc.date.available2017-11-14T18:45:28Z-
dc.date.issued2004-11-01-
dc.identifier.issn0959-4973fr
dc.identifier.urihttp://hdl.handle.net/20.500.11794/15828-
dc.description.abstractCaveolins are highly expressed in terminally differentiated cells, but this expression is down-regulated in various cancer cell lines. Exposure to low doses of paclitaxel (taxol) is sufficient to up-regulate caveolin-1, suggesting that a mild cytotoxic stress induces a response implying caveolin and caveolae. Here we show that this up-regulation is sustained even after the cessation of paclitaxel treatment. After exposure to a cytostatic dose of paclitaxel (50 nM), A549 lung cancer cells are blocked in the G2/M cell cycle phase. After removal of paclitaxel, cell death occurs, accompanied with an increase in caveolin expression, suggesting an effect of caveolin in this process. Three days post-paclitaxel treatment, surviving A549 cells were passaged and only a half of them adhered to the culture dish. Adhering cells (still mainly in the G2/M cell cycle phase) were still unable to grow and progressively entered in an apoptotic state. This study suggests that effects of a low dose of paclitaxel were still present even 1 week after drug removal and that caveolin-1 is a good marker of cytotoxicity.fr
dc.languageengfr
dc.publisherRapid Communications of Oxfordfr
dc.subjectCaveolinfr
dc.subjectPaclitaxel caveolaefr
dc.subjectLung cancerfr
dc.titleG2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells : caveolin-1 as a marker of cytotoxicity.fr
dc.typeCOAR1_1::Texte::Périodique::Revue::Contribution à un journal::Article::Article de recherchefr
dcterms.bibliographicCitationAnti-cancer drugs, Vol. 15 (10), 961-967 (2004)fr
dc.identifier.pubmed15514565fr
dc.subject.rvmCavéolinesfr
dc.subject.rvmPoumons -- Cancerfr
dc.subject.rvmCellules cancéreusesfr
dc.subject.rvmPaclitaxelfr
dc.subject.rvmMarqueurs biologiquesfr
rioxxterms.versionAccepted Manuscriptfr
rioxxterms.project.funder_nameCanadian Institutes of Health Researchfr
rioxxterms.project.funder_nameFondation J. D. Béginfr
rioxxterms.project.funder_nameAssociation pulmonaire du Québecfr
bul.rights.periodeEmbargo12 moisfr
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
8.pdf442.71 kBAdobe PDFThumbnail
View/Open
Finales.pdf802.2 kBAdobe PDFThumbnail
View/Open
All documents in CorpusUL are protected by Copyright Act of Canada.